Volume 2, Issue 7.
Marc Rendell, MD covers the important topic of the Safety of the Newer Oral Diabetes Treatment Agents in the format of case-study scenarios for the clinical practice.
Podcast (ediabetes): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS